Marathon Asset Management Ltd lessened its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 4.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 93,534 shares of the medical technology company's stock after selling 3,905 shares during the quarter. Marathon Asset Management Ltd owned approximately 0.20% of Teleflex worth $16,647,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Avior Wealth Management LLC increased its position in Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new stake in Teleflex during the 3rd quarter valued at approximately $40,000. True Wealth Design LLC grew its position in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock worth $41,000 after buying an additional 166 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $54,000. Finally, IFP Advisors Inc grew its position in shares of Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have recently commented on TFX shares. Raymond James downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and reduced their price objective for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. Wells Fargo & Company reduced their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Truist Financial reduced their price target on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research report on Monday. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $182.63.
Check Out Our Latest Research Report on TFX
Teleflex Stock Performance
Shares of NYSE:TFX traded up $3.59 during midday trading on Wednesday, reaching $134.38. The company had a trading volume of 1,400,165 shares, compared to its average volume of 813,759. The company's 50 day moving average price is $172.79 and its 200 day moving average price is $202.69. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market cap of $6.24 billion, a P/E ratio of 26.71, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.90.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex's dividend payout ratio is presently 95.77%.
Teleflex Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Recommended Stories

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.